293.43M
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Medical - Devices
Industry

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion.

Similar securities

Based on sector and market capitalization

Report issue